What does Oneness Biotech Co., Ltd. do?

Oneness Biotech Co., Ltd. (4743.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4743.TWO's market cap?

Oneness Biotech Co., Ltd. (4743.TWO) has a market capitalization of approximately $22.91 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4743.TWO pay a dividend?

Yes — Oneness Biotech Co., Ltd. (4743.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

4743.TWO

Oneness Biotech Co., Ltd.

TWO·Biotechnology · Healthcare

NT$47.80NT$0.85+1.81%

Market capNT$22.91B·Market closed·Aug 26 5:30 AM UTC

Price Chart

NT$47.80+NT$0.85 (+1.81%)today

−71.23%CAGR −22.06%

Select date range

FromTo

Jun 19, 2009Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)NT$0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.094

Ex-Dividend DateJun 16

Payment DateJul 21

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 5

Last Report DateAug 11

Reported vs EstimateNT$0.52

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$149.22M

Net IncomeNT$59.65M

Net Margin40.0%

Operating Cash Flow−NT$174.55M

Capital ExpendituresNT$15.96M

Free Cash Flow−NT$190.51M

Return on Equity0.6%

Return on Invested Capital−1.8%

Net CashNT$5.08B

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4743.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4743.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4743.TWO and 80,000+ other tickers.

About Oneness Biotech Co., Ltd.

Oneness Biotech Co., Ltd., headquartered in Taipei City, Taiwan, functions as a biopharmaceutical enterprise primarily dedicated to the discovery and advancement of novel therapeutic agents, in addition to selling pharmaceutical and health-related merchandise. The company's operations are divided into its New Drug Research and Development segment and its Agricultural Products Cultivation segment. Its advanced therapeutic candidate, ON101, is currently undergoing Phase III clinical trials for the treatment of chronic diabetic foot ulcers. Additionally, OB318, an experimental anti-cancer drug…

CEO: Shuling Cheng
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 180
Website: www.onenessbio.com.tw

Peers

Peers Tab

6535.TWO

Lumosa Therapeutics Co., Ltd.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4743.TWO

What does Oneness Biotech Co., Ltd. do?: Oneness Biotech Co., Ltd. (4743.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4743.TWO's market cap?: Oneness Biotech Co., Ltd. (4743.TWO) has a market capitalization of approximately $22.91 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4743.TWO pay a dividend?: Yes — Oneness Biotech Co., Ltd. (4743.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.